About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Photovoltaic retinal implant shows early promise for geographic atrophy

This prospective, first-in-human clinical trial assessed the safety and efficacy of a wireless photovoltaic retinal implant (PRIMA) in patients with geographic atrophy. Source: AAO

Posted on: Oct 7 2020
By: Saratoga Opthalmology
Leave a reponse

Very early endoscopic DCR shows encouraging outcomes in suppurative dacryocystitis

Researchers detail the outcomes of very early endoscopic dacryocystorhinostomy (DCR) in patients with acute dacryocystitis and abscess formation. Source: AAO

Posted on: Oct 6 2020
By: Saratoga Opthalmology
Leave a reponse

Protocol T extension study details 5-year outcomes after anti-VEGF for DME

This study assessed 5-year outcomes in eyes initially treated with anti-VEGF therapy for central-involved diabetic macular edema (DME) during a 2-year study. Source: AAO

Posted on: Oct 5 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: Gene therapy, presbyopia drops, lazy eye

This week, a gene therapy for Leber hereditary optic neuropathy gains orphan drug designation, a novel eye drop for presbyopia is cleared for phase 2 trials and a common antidepressant shows early promise for amblyopia. Source: AAO

Posted on: Oct 2 2020
By: Saratoga Opthalmology
Leave a reponse

Wearing eyeglasses daily linked to lower susceptibility to COVID-19

In this study, investigators examined the association between daily wearing of eyeglasses and susceptibility to COVID-19. Source: AAO

Posted on: Oct 1 2020
By: Saratoga Opthalmology
Leave a reponse

Coxsackievirus may be tied to acute posterior multifocal placoid pigment epitheliopathy

This was a retrospective, single-center case series of 7 patients diagnosed with acute posterior multifocal placoid pigment epitheliopathy. Source: AAO

Posted on: Sep 30 2020
By: Saratoga Opthalmology
Leave a reponse

Preservative-free antihistamine drops gain FDA clearance

The FDA has approved the first preservative-free, over-the-counter antihistamine drops for allergic conjunctivitis. Source: AAO

Posted on: Sep 29 2020
By: Saratoga Opthalmology
Leave a reponse

Breath shields offer variable protection

This experimental study is the first to test the efficacy of slit-lamp breath shields in preventing droplet spray from a simulated sneeze. Source: AAO

Posted on: Sep 29 2020
By: Saratoga Opthalmology
Leave a reponse

Systemic steroids continue to be prescribed for CSC despite potential risks

This retrospective study analyzed the frequency of systemic corticosteroid prescription before and after central serous chorioretinopathy (CSC) diagnosis. Source: AAO

Posted on: Sep 28 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: Tocilizumab, fast track, retinas in a dish

This week, tocilizumab reduces the need for mechanical ventilation due to COVID-19, a gene therapy for dry AMD is fast-tracked by the FDA and Swiss scientists develop functional retinas in the lab. Source: AAO